AstraZeneca appears to be back on its track as producer of breakthrough cancer treatments with the promising results of AZD9291 and MEDI4736 in clinical trials.
AstraZeneca appears to be back on its track as producer of breakthrough cancer treatments with the promising results of AZD9291 and MEDI4736 in clinical trials.